AhR has long been associated with a variety of cancers, and its expression is elevated and the receptor chronically active in tumors, including T cell leukemia [23], B cell lymphoma [24], hepatocellular carcinoma [25], glioblastoma [26], and lung cancer [27], among others. Here, AHR is linked to lung carcinoma.